Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong · Delayed Price · Currency is HKD 6.68
+0.08 (1.21%)
At close: Mar 27, 2026
HKG:0719 Revenue
In the year 2025, Shandong Xinhua Pharmaceutical Company had annual revenue of 8.75B CNY with 3.41% growth. Shandong Xinhua Pharmaceutical Company had revenue of 1.99B in the quarter ending December 31, 2025, with 15.01% growth.
Revenue
8.75B CNY
Revenue Growth
+3.41%
P/S Ratio
1.01
Revenue / Employee
1.22M CNY
Employees
7,159
Market Cap
9.80B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.75B | 288.41M | 3.41% |
| Dec 31, 2024 | 8.47B | 365.47M | 4.51% |
| Dec 31, 2023 | 8.10B | 597.86M | 7.97% |
| Jan 1, 2023 | 7.50B | 942.91M | 14.37% |
| Dec 31, 2021 | 6.56B | 554.49M | 9.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Traditional Chinese Medicine Holdings Co. | 16.41B |
| Luye Pharma Group | 6.76B |
| SSY Group | 4.17B |
| Consun Pharmaceutical Group | 3.80B |
| China Shineway Pharmaceutical Group | 3.49B |
| Sihuan Pharmaceutical Holdings Group | 2.30B |
| Beijing Tong Ren Tang Chinese Medicine Company | 1.51B |
| CanSino Biologics | 1.19B |
Shandong Xinhua Pharmaceutical Company News
- 5 weeks ago - Viral dance challenge lifted Chinese ibuprofen maker’s shares – now they are languishing - South China Morning Post